Non Invasive Prenatal Testing Market Size, Share & Trends Report

Non Invasive Prenatal Testing Market Size, Share & Trends Analysis Report By Gestation Period, By Pregnancy Risk, By Method, By Technology, By Product, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-310-2
  • Number of Pages: 100
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the non invasive prenatal testing market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for non invasive prenatal testing market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of non invasive prenatal testing market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Non Invasive Prenatal Testing Market Categorization:

The non invasive prenatal testing market was categorized into eight segments, namely gestation period (0-12 Weeks, 13-24 Weeks, 25-36 Weeks), pregnancy risk (High & Average Risk, Low Risk), method (Ultrasound Detection, Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests), technology (NGS, Array Technology, PCR), product (Consumables & Reagents, Instruments), application (Trisomy, Microdeletion Syndrome), end-use (Hospitals & Clinics, Diagnostic Laboratories), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).

Segment Market Methodology:

The non invasive prenatal testing market was segmented into gestation period, pregnancy risk, method, technology, product, application, end-use, and region. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The non invasive prenatal testing market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina, South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Non invasive prenatal testing market companies & financials:

The non invasive prenatal testing market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Natera, Inc. -The company functions through three diagnostic segments: Oncology, Reproductive Health, and Organ Transplant. Its products and services include carrier screening, prenatal testing, miscarriage tests, and preimplantation tests. Natera operates laboratories that are CLIA approved for prenatal as well as preconception genetic testing services. Natera's technologies are applied in over 100 countries.

  • Centogene N.V. - The company specializes in rare hereditary diseases and genetic testing. It functions in two segments: Pharma and Diagnostics. It has CAP as well as CLIA accreditations. It owns a broad international network and has collaborations with 30 pharmaceutical companies, such as Evotec AG, Denali Therapeutics, Orphazyme, Chiesi Germany, and Aldeyra Therapeutics. The company is also functional in orphan drugs segment and is leveraging knowledge for drug development.

  • Illumina, Inc. - The company develops, manufactures, and commercializes integrated systems for the study of biological function and genetic variation. The company provides a range of products and services that serve genotyping, sequencing, and gene expression markets. It provides products to pharmaceutical companies, genomic research centers, clinical research organizations, academic institutions, and biotechnology companies. The company's tools provide scientists the ability to perform genetic tests required for extraction of medical information from advances in proteomics and genomics.

  • Eurofins Scientific - The company operates through various subsidiaries. It provides solutions for environment, food, pharmaceuticals, agro science, CRO services, and cosmetic testing services. It offers over 20,000 analytical tests and has 800 operational laboratories across 50 countries. It handles a network of over 900 companies globally.

  • MedGenome - It is an Indian diagnostic company that provides over 475 genetic tests for oncology, pediatrics, hematology, neurology, endocrinology, ophthalmology, nephrology, etc. It has a strong presence in the South Asian market. The company holds over 1,600 hospitals across South Asia and India. The company has also expanded its services across South Asia, Africa, the Middle East, and Eastern Europe in the past 3 years. It operates through CAP-accredited laboratories that allow affordable management of health.

  • QIAGEN - QIAGEN provides samples and assay technologies for academic research, applied testing, molecular diagnostics, and pharmaceutical research. The company markets over 500 products including consumable kits and automation systems. In addition, the company offers products for NGS, cancer research, forensics, informatics, oncology, infectious diseases, and TB management.

  • F. Hoffmann-La Roche Ltd. - It is a healthcare company with business operations in the following two divisions: pharmaceuticals and diagnostics. Roche Diagnostics comprises Roche Professional Diagnostics (RPD), Roche Molecular Diagnostics (RMD), Roche Tissue Diagnostics, and Roche Diabetes Care. RMD, a segment of Roche diagnostics, is engaged in development, manufacture, and distribution of tests based on PCR technology & medical diagnostic products, platforms, and services

  • Myriad Women's Health, Inc.- It is a genetic screening and testing company. The company is a combination of Myriad Preventive Care (Myriad Genetic Laboratories, Inc.) and Counsyl, Inc. Its products include prenatal testing, hereditary cancer testing, and carrier screening. The company also offers services for making genetic testing more accessible and affordable for patients along with counseling.

  • Biora Therapeutics - It is engaged in the development and commercialization of precision medicine & molecular testing products. It provides its products in carrier screening, prenatal testing & care, and hereditary cancer risk testing. This solution allows doctors and patients to make important decisions. The company holds pipeline products in precision medicine segment. It focuses on Gastrointestinal (GI) tract diseases to expand its product portfolio by working on GI therapeutics, ingestible GI diagnostics, and targeted GI sampling.

  • Quest Diagnostics Incorporated - It is a leading provider of diagnostic information services. The company offers wide range of tests and has more than 2,250 locations across the U.S. Its cfDNA technology allows prenatal testing for the detection of chromosomal abnormalities safely. The main operational regions include the U.S., the UK, Mexico, and Brazil. Quest Diagnostics offers solutions in the fields of neurology, oncology, cardiovascular diseases, and infectious diseases.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Non Invasive Prenatal Testing Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2022, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Non Invasive Prenatal Testing Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation



This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon